FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

929360071000036103: Medicinal product unit of use reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288211000168116 MPUU (medicinal product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507151000036113 Medicinal product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
965507161000036111 Medicinal product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4351141000168117 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more equivalent Trade Product Units of Use.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


7425 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product unit of use reference set Developed by Australian Digital Health Agency true Inferred relationship Some 615170453
Medicinal product unit of use reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1364130978
Medicinal product unit of use reference set Is a Simple type reference set true Inferred relationship Some

Members
etoposide phosphate 1.136 g (etoposide 1 g) injection, vial
etoposide phosphate 113.6 mg (etoposide 100 mg) injection, vial
etoposide phosphate 567.8 mg (etoposide 500 mg) injection, vial
etoricoxib 120 mg tablet
etoricoxib 30 mg tablet
etoricoxib 60 mg tablet
etoricoxib 90 mg tablet
etravirine 100 mg tablet
etravirine 200 mg tablet
menthol 2% + eucalyptus oil 10% inhalation solution
methyl salicylate 25% v/v + eucalyptus oil 10% v/v + menthol 4% w/v liniment
eucalyptus oil 1 g/g inhalation solution
eucalyptus oil 1 mL/mL inhalation solution
eucalyptus oil 1 mL/mL oil
methyl salicylate 25% + eucalyptus oil 10% + menthol 4% cream
methyl salicylate 25% w/w + eucalyptus oil 10% w/w + menthol 4% w/w liniment
eucalyptus oil 11% + lemon tea tree oil 1% solution
eucalyptus oil 0.2% + peppermint oil 1% gel
eucalyptus oil 2.5% cream
eucalyptus oil 250 mg/g spray
methyl salicylate 28.3% + eucalyptus oil 8.8% + menthol 2% cream
methyl salicylate 28.3% + eucalyptus oil 8.8% + menthol 2% gel
eucalyptus oil 8.8% + menthol liquid 3.8% + methyl salicylate 28.3% cream
eucalyptus oil 8.8% + menthol liquid 3.8% + methyl salicylate 28.3% gel
methyl salicylate 7.5% + eucalyptus oil 9% + menthol 3% cream
eucalyptus oil 9% + peppermint oil 2% cream
menthol 2% + eucalyptus oil 9.16% inhalation solution
eucalyptus radiata 3.86% + melaleuca oil 4.25% liniment
evening primrose oil 1 g capsule
everolimus 1 mg tablet
everolimus 10 mg tablet
everolimus 100 microgram dispersible tablet
everolimus 2 mg dispersible tablet
everolimus 2.5 mg tablet
everolimus 250 microgram dispersible tablet
everolimus 250 microgram tablet
everolimus 3 mg dispersible tablet
everolimus 5 mg dispersible tablet
everolimus 5 mg tablet
everolimus 500 microgram tablet
everolimus 7.5 mg tablet
everolimus 750 microgram tablet
evolocumab 140 mg/mL injection, pen device
evolocumab 140 mg/mL injection, syringe
evolocumab 420 mg / 3.5 mL injection, 3.5 mL cartridge (medicinal product unit of use)
exametazime 500 microgram injection, vial
exemestane 25 mg tablet
exenatide 10 microgram/0.04 mL injection, 2.4 mL pen device
exenatide 2 mg/0.85 mL modified release injection, 2 mL pen device
exenatide 2 mg modified release injection, chamber
exenatide 2 mg modified release injection, vial
exenatide 5 microgram/0.02 mL injection, 1.2 mL pen device
ezetimibe 10 mg + simvastatin 10 mg tablet
ezetimibe 10 mg + simvastatin 20 mg tablet
ezetimibe 10 mg + simvastatin 40 mg tablet
ezetimibe 10 mg + simvastatin 80 mg tablet
ezetimibe 10 mg tablet
factor II 200 units + factor VII 100 units + factor IX 200 units + factor X 220 units + protein C 150 units + protein S 120 units injection, vial
factor II 400 units + factor VII 200 units + factor IX 400 units + factor X 440 units + protein C 300 units + protein S 240 units injection, vial
factor II 500 units + factor IX 500 units + factor X 500 units injection, vial
factor II 800 units + factor VII 400 units + factor IX 800 units + factor X 880 units + protein C 600 units + protein S 480 units injection, vial
factor IX 1000 units injection, vial
factor IX 500 units injection, vial
factor VIII 1000 units + von Willebrand factor 2000 units injection, 1 vial
factor VIII 1000 units + von Willebrand factor 2400 units injection, 1 vial
factor VIII 1000 units injection, vial
factor VIII 250 units + von Willebrand factor 500 units injection, 1 vial
factor VIII 250 units + von Willebrand factor 600 units injection, 1 vial
factor VIII 250 units injection, vial
factor VIII 500 units + von Willebrand factor 1000 units injection, 1 vial
factor VIII 500 units + von Willebrand factor 1200 units injection, 1 vial
factor VIII 500 units injection, vial
factor VIII inhibitor bypassing fraction 1000 units injection, vial
factor VIII inhibitor bypassing fraction 2500 units injection, vial
factor VIII inhibitor bypassing fraction 500 units injection, vial
fibrinogen 250 mg/5 mL + factor XIII 10 units/5 mL solution, vial
fibrinogen 50 mg/mL + factor XIII 2 units/mL solution, vial
fibrinogen 100 mg/2 mL + factor XIII 4 units/2 mL solution, vial
famciclovir 125 mg tablet
famciclovir 250 mg tablet
famciclovir 500 mg tablet
famotidine 20 mg tablet
famotidine 40 mg tablet
fampridine 10 mg modified release tablet
tozinameran 15 microgram/0.3 mL + famtozinameran 15 microgram/0.3 mL injection, 2.25 mL vial
faricimab 6 mg/0.05 mL intraocular injection, vial
febuxostat 80 mg tablet
felodipine 10 mg modified release tablet
ramipril 2.5 mg + felodipine 2.5 mg modified release tablet
felodipine 2.5 mg modified release tablet
ramipril 5 mg + felodipine 5 mg modified release tablet
felodipine 5 mg modified release tablet
prilocaine hydrochloride 3% (54 mg/1.8 mL) + felypressin 0.054 units/1.8 mL injection, cartridge
prilocaine hydrochloride 3% (66 mg/2.2 mL) + felypressin 0.066 units/2.2 mL injection, cartridge
fenofibrate 145 mg tablet
fenofibrate 48 mg tablet
fentanyl 100 microgram/actuation nasal spray, actuation
fentanyl 100 microgram/hour patch
fentanyl 100 microgram/2 mL injection, ampoule
fentanyl 100 microgram orally disintegrating tablet
fentanyl 100 microgram sublingual tablet

Start Previous Page 34 of 75 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start